Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05543798

VT Ablation in the iCMR

Vision-MR Ablation Catheter 2.0 for the Treatment of Ventricular Tachycardia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Imricor Medical Systems · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The VISABL-VT is a prospective, single-arm, multi-center, interventional investigation of the safety and efficacy of radiofrequency (RF) ablation of ventricular tachycardia associated with ischemic cardiomyopathy performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment.

Conditions

Interventions

TypeNameDescription
DEVICEVision-MR Ablation Catheter 2.0Catheter ablation of ventricular tachycardia

Timeline

Start date
2025-04-10
Primary completion
2026-12-01
Completion
2027-06-01
First posted
2022-09-16
Last updated
2026-01-08

Locations

3 sites across 2 countries: Germany, Netherlands

Source: ClinicalTrials.gov record NCT05543798. Inclusion in this directory is not an endorsement.

VT Ablation in the iCMR (NCT05543798) · Clinical Trials Directory